Objectives: To assess the performance of screening for preeclampsia (PE) by mean arterial pressure (MAP) at 11-13 and at 20-24 weeks' gestation. Methods: MAP was measured at 11-13 and 20-24 weeks in 17,383 singleton pregnancies, including 70 with early PE, requiring delivery <34 weeks' gestation, 143 with preterm PE, delivering <37 weeks and 537 with total PE. MAP was expressed as multiple of the median (MoM) after adjustment for maternal characteristics and corrected for adverse pregnancy outcomes. The performance of screening for PE by maternal characteristics and MAP MoM at 11-13 weeks (MAP-1), MAP MoM at 20-24 weeks (MAP-2) and their combination was evaluated. Results: In screening by maternal characteristics and MAP-1, at a false-positive rate (FPR) of 10%, the detection rates (DR) of early PE, preterm PE and total PE were 74.3, 62.9 and 49.3%, respectively; the DR at FPR of 5% were 52.9, 42.7 and 35.8%. In screening by MAP-1 and MAP-2 the DR at FPR of 10%, were 84.3, 65.7 and 52.5%; the DR at FPR of 5% were 60.0, 49.7 and 37.6%, respectively. Conclusions: Performance of screening for PE by MAP is best when measurements are taken at both 11-13 and 20-24 weeks' gestation than at only one of these gestational ranges.

Keywords:
Preeclampsia, Mean arterial pressure, First trimester, Second trimester, Screening, Pyramid of pregnancy care
1.
World Health Organization (WHO): Make Every Mother and Child Count. World Health Report, 2005. Geneva, WHO, 2005.
2.
Confidential Enquiry into Maternal and Child Health (CEMACH) Perinatal Mortality 2006: England, Wales and Northern Ireland. London, CEMACH, 2008.
3.
Duley L: The global impact of pre-eclampsia and eclampsia. Semin Perinatol 2009;33:130-137.
4.
Poon LC, Kametas NA, Maiz N, Akolekar R, Nicolaides KH: First-trimester prediction of hypertensive disorders in pregnancy. Hypertension 2009;53:812-818.
5.
Akolekar R, Syngelaki A, Poon L, Wright D, Nicolaides KH: Competing risks model in early screening for preeclampsia by biophysical and biochemical markers. Fetal Diagn Ther 2013;33:8-15.
6.
Poon LC, Zymeri NA, Zamprakou A, Syngelaki A, Nicolaides KH: Protocol for measurement of mean arterial pressure at 11-13 weeks' gestation. Fetal Diagn Ther 2012;31:42-48.
7.
Wright D, Akolekar R, Syngelaki A, Poon LCY, Nicolaides KH: A competing risks model in early screening for preeclampsia. Fetal Diagn Ther 2012;32:171-178.
8.
Robinson HP, Fleming JE: A critical evaluation of sonar crown-rump length measurements. Br J Obstet Gynaecol 1975;82:702-710.
9.
Kagan KO, Wright D, Valencia C, Maiz N, Nicolaides KH: Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free β-hCG and pregnancy-associated plasma protein-A. Hum Reprod 2008;23:1968-1975.
10.
Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM: The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001;20:IX-XIV.
11.
Poon LC, Volpe N, Muto B, Syngelaki A, Nicolaides KH: Birthweight with gestation and maternal characteristics in live births and stillbirths. Fetal Diagn Ther 2012;32:156-165.
12.
Kalbfleisch JD, Prentice RL: The Statistical Analysis of Failure Time Data, ed 2. New York, Wiley, 2002.
13.
R Core Team: A Language and Environment for Statistical Computing. Vienna, R Foundation for Statistical Computing, 2013. http://www.R-project.org/.
14.
Fallis NE, Langford HG: Relation of second-trimester blood pressure to toxemia of pregnancy in the primigravid patient. Am J Obstet Gynecol 1963;87:123-125.
15.
Page EW, Christianson R: The impact of mean arterial pressure in the middle trimester upon the outcome of pregnancy. Am J Obstet Gynecol 1976;125:740-746.
16.
Friedman EA, Neff RK: Systolic and mean arterial blood pressure; in Friedman EA, Neff RK (eds): Pregnancy Hypertension. A systematic Evaluation of Clinical Diagnostic Criteria. Littleton/MA, PSG Publishing, 1977, pp 212-219.
17.
Robrecht D, Schriever M, Rasenack R, Steiner H, Kaltenbach FJ: The mean blood pressure in the second trimester (MAP-2) as a valuable aid in the early recognition of the pregnancies with a risk of hypertension. Geburtshilfe Frauenheilkd 1980;40:121-124.
18.
Öney T, Kaulhausen H: The value of the mean arterial blood pressure in the second trimester (MAP-2 value) as a predictor of pregnancy-induced hypertension and preeclampsia. A preliminary report. Clin Exp Hypertens B 1983;2:211-216.
19.
Mahanna I, Algeri T, Cigarini C, Zinelli G: Arterial pressure, MAP and dynamic tests in the monitoring of pregnancy. Ann Ostet Ginecol Med Perinat 1983;104:248-255.
20.
Moutquin JM, Rainville C, Giroux L, Raynauld P, Amyot G, Bilodeau R, Pelland N: A prospective study of blood pressure in pregnancy: prediction of preeclampsia. Am J Obstet Gynecol 1985;151:191-196.
21.
Villar MA, Sibai BM: Clinical significance of elevated mean arterial blood pressure in second trimester and threshold increase in systolic or diastolic blood pressure during third trimester. Am J Obstet Gynecol 1989;160:419-423.
22.
Ales KL, Norton ME, Druzin ML: Early prediction of antepartum hypertension. Obstet Gynecol 1989;73:928-933.
23.
Conde-Agudelo A, Belizan JM, Lede R, Bergel EF: What does an elevated mean arterial pressure in the second half of pregnancy predict - gestational hypertension or preeclampsia? Am J Obstet Gynecol 1993;169:509-514.
24.
Kyle PM, Clark SJ, Buckley D, Kissane J, Coats AJ, de Swiet M, Redman CW: Second trimester ambulatory blood pressure in nulliparous pregnancy: a useful screening test for pre-eclampsia? BJOG 1993;100:914-919.
25.
Rogers MS, Chung T, Baldwin S: A reappraisal of second trimester mean arterial pressure as a predictor of pregnancy induced hypertension. J Obstet Gynaecol 1994;14:232-236.
26.
Atterbury JL, Groome LJ, Baker SL: Elevated midtrimester mean arterial blood pressure in women with severe preeclampsia. Appl Nurs Res 1996;9:161-166.
27.
Higgins JR, Walshe JJ, Halligan A, O'Brien E, Conroy R, Darling MR: Can 24-hour ambulatory blood pressure measurement predict the development of hypertension in primigravidae? BJOG 1997;104:356-362.
28.
Caritis S, Sibai B, Hauth J, Lindheimer M, VanDorsten P, Klebanoff M, Thom E, Landon M, Paul R, Miodovnik M, Meis P, Thurnau G, Dombrowski M, McNellis D, Roberts J: Predictors of pre-eclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol 1998;179:946-951.
29.
Shaarawy M, Abdel-Magid AM: Plasma endothelin-1 and mean arterial pressure in the prediction of pre-eclampsia. Int J Gynaecol Obstet 2000;68:105-111.
30.
Stamilio DM, Sehdev HM, Morgan MA, Propert K, Macones GA: Can antenatal clinical and biochemical markers predict the development of severe preeclampsia? Am J Obstet Gynecol 2000;182:589-594.
31.
Brown MA, Bowyer L, McHugh L, Davis GK, Mangos G, Jones M: Twenty-four hour automated blood pressure monitoring as a predictor of preeclampsia. Am J Obstet Gynecol 2001;185:618-622.
32.
Iwasaki R, Ohkuchi A, Furuta I, Ojima T, Matsubara S, Sato I, Minakami H: Relationship between blood pressure level in early pregnancy and subsequent changes in blood pressure during pregnancy. Acta Obstet Gynecol Scand 2002;81:918-925.
33.
Ebeigbe PN, Gharoro EP: A raised mid-trimester mean arterial blood pressure: is it predictive of pregnancy-induced hypertension in Nigerian pregnant women? Niger Postgrad Med J 2004;11:294-297.
34.
Onwudiwe N, Yu CK, Poon LCY, Spiliopoulos I, Nicolaides KH: Prediction of pre-eclampsia by a combination of maternal history, uterine artery Doppler and mean arterial pressure. Ultrasound Obstet Gynecol 2008;32:877-883.
35.
Ministry of Health Report: 1929 memorandum on antenatal clinics: their conduct and scope. London, HMSO, 1930.
36.
Nicolaides KH: Turning the pyramid of prenatal care. Fetal Diagn Ther 2011;29:183-196.
37.
Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S, Forest JC, Giguere Y: Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol 2010;116:402-414.
38.
Roberge S, Villa P, Nicolaides KH, Giguère Y, Vainio M, Bakthi A, Ebrashy A, Bujold E: Early administration of low dose aspirin for the prevention of preterm and term pre-eclampsia: a systematic review and meta-analysis. Fetal Diagn Ther 2012;31:141-146.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.